Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06372717
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-03-11
Brief Title:
A Study to Investigate APL-4098 Alone andor in Combination With Azacitidine in RR AML and High-Risk MDS
Sponsor:
Apollo Therapeutics Ltd
Organization:
Apollo Therapeutics Ltd
Organization Data
Organization:
Apollo Therapeutics Ltd
Class:
INDUSTRY
Study ID:
AP30CP01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Apollo Therapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None